Human immunodeficiency virus 1 dual-target nucleic acid technology improves blood safety: 5 years of experience of the German Red Cross blood donor service Baden-Württemberg-Hessen.
Hourfar K, Eberle J, Müller M, Micha Nübling C, Chudy M, Kress J, Gürtler L, Mayr-Wohlfart U, Schrezenmeier H, Hellmann I, Luhm J, Kraas S, Ringwald J, Gubbe K, Frank K, Karl A, Tonn T, Jaeger M, Sireis W, Seifried E, Schmidt M.
Hourfar K, et al. Among authors: frank k.
Transfusion. 2018 Dec;58(12):2886-2893. doi: 10.1111/trf.14919. Epub 2018 Oct 16.
Transfusion. 2018.
PMID: 30325043